HOME | KHIDI USA

WELCOME TO KHIDI USA

KHIDI KOREA

The Korea Health Industry Development Institute (KHIDI) is a Korean government institution established in 1999 that provides systematic and professional support for the improvement of public health and enhancement of the international competitiveness in the healthcare industry. To deliver its mission, KHIDI provides support to strengthen Korea’s R&D capabilities and to accelerate the globalization of the Korean healthcare industry. KHIDI also aims to develop human resources in the industry and support startups to ensure their development as growth engines. Furthermore, KHIDI’s work to establish a strong healthcare infrastructure through policies and technology utilization will reinforce supporting framework for drug development and reflect changes in the healthcare industrial ecosystem.

KHIDI USA

KHIDI USA was established in 2008 to acquire overseas authorization and to facilitate the US expansion of Korean companies and institutions in the healthcare industry by serving as a bridge between Korea and the US. To help connect the two industries, we provide consultation for US market entry and share our expertise, resources, and industry connections in the fields of pharmaceutical/biopharmaceutical, medical devices, cosmetics, and other healthcare-related fields. With our market insights and knowledge of the local healthcare landscape, KHIDI USA aims to enhance the healthcare industry, bring innovation, and accelerate the growth of Korean healthcare companies in the US market.

Advanced Bio & Health
Strategic Hub

The Advanced Bio & Health Strategic Hub serves as a dedicated R2BD bridge connecting Korea's cutting-edge bio-health research with the world-leading innovation ecosystem in Boston and across the United States. To spearhead the global paradigm shift and transition into a first-mover, the Hub operates across three strategic pillars: accelerating bilateral joint R&D and top-tier talent circulation, expanding a unified Virtual U.S. Cluster, and driving network-based commercialization. Through its comprehensive "5 Bridges" initiatives—spanning R&D matching, talent exchange, regulatory intelligence, cluster networking, and market entry support—the Hub empowers researchers and enterprises across the entire innovation lifecycle. Guided by a phased strategic roadmap, the Hub is advancing from dedicated infrastructure establishment to deep integration within the U.S. inner circle, ultimately fostering sustainable global partnerships and nationwide bio-health expansion.

OUR UPDATES

UKC (US-Korea Conference) 2026 (8.5-8.8)

Topic: From Imagination to Innovation – Into Reality Date: August 5-8, 2026 Venue: Omni Orlando Resort Link: https://www.ukc.ksea.org/

KHIDI USA President: “For K-Bio to Succeed in the U.S., Clinical PoC Funding and Global Business Development Talent Are Essential”

By Hyun-woong Lee | San Diego(2026-06-27 14:38, The Munhwa Ilbo) “Global investors are no longer willing to invest based solely on the promise of platform technologies or their future potential.” Hyunchul Kim, President of the U.S. Office of the Korea Health Industry Development Institute (KHIDI), shared this assessment in an interview with Munhwa Ilbo during the BIO International Convention 2026, held this week in Boston. According to Kim, while global interest in Korean bio

KHIDI USA President: “Expanding Support for K-Bio Beyond Boston to the Entire United States”

Advanced Bio Innovation Hub to Serve as a Comprehensive Platform Connecting Industry, Academia, Research, and Healthcare By Sang-woo Roh | San Diego (2026-06-28 09:00, etoday) The Korea Health Industry Development Institute (KHIDI) is expanding its support system for Korean biotech companies beyond Boston to encompass the entire United States. Building upon its successful Boston model, KHIDI aims to evolve into a comprehensive platform that supports every stage of global mark

KHIDI Expands K-Bio’s U.S. East Coast Footprint with the “Boston Success Formula” (6.5.2026)

KHIDI Builds a Public-Private Partnership to Accelerate K-Bio’s Expansion into the U.S. Market Collaborating with KOTRA, Hallym University, SK Biopharmaceuticals, and the Korean American Society in Biotech and Pharmaceuticals (KASBP) As Korea’s biohealth exports continue to reach record highs, the Korea Health Industry Development Institute (KHIDI) is strengthening public-private partnerships to accelerate the successful entry of promising Korean biotech startups into the U.S

Korea-Boston Global Deep Tech Bridge 2026 Successfully Held (5.21.2026)

Building a Platform for Korea-Boston Innovation Ecosystem Collaboration The Korea-Boston Global Deep Tech Bridge Program 2026, jointly hosted by the Consulate General of the Republic of Korea in Boston and four Korean public institutions—KHIDI, KEIT, TIPA, and SNUH—was successfully held on May 21, 2026. The event attracted more than 500 venture capitalists, researchers, entrepreneurs, and industry leaders, providing a dynamic platform for collaboration between Korea’s innovat